Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Royal DSM    DSM   NL0000009827

ROYAL DSM

(DSM)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Royal DSM : DSM will further upgrade its Vitamin C facility in Jiangshan, China in summer 2019

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/17/2019 | 04:50am EST

This shutdown has started earlier this month, with the latest upgrades to be completed by start Q4 2019.

DSM assures security of supply of Vitamin C to its contracted customers, also during the shutdown.

Fully aligned with its Quality for Life principles, DSM continuously invests in meeting expectations of customers, governments and employees in terms of quality, reliability, traceability and sustainability. Vitamin C from Jiangshan, China, is already the lowest carbon footprint Vitamin C on the market, thanks to this continuous investment program.

Disclaimer

Koninklijke DSM NV published this content on 17 July 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 July 2019 08:49:08 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ROYAL DSM
11/05DSM : reorganizes engineering plastics distribution network in North America
BU
11/05ROYAL DSM : DSM - repurchase of shares (28 October - 1 November 2019)
PU
11/05ROYAL DSM : DSM reports results first nine months 2019 results
PU
10/31ROYAL DSM : DSM releases first-ever UL-certified flame-retardant PA6/66 material..
PU
10/31KONINKLIJKE DSM N.V. : quaterly earnings release
10/29ROYAL DSM : DSM and Twikit drive innovation with end-to-end 3D printing solution..
PU
10/29ROYAL DSM : New mobility, the future's begun
PU
10/29ROYAL DSM : DSM - repurchase of shares (21-25 October 2019)
PU
10/25ROYAL DSM : DSM and ECOR announce partnership with innovators in furniture indus..
PU
10/23ROYAL DSM : DSM and AMT partner to optimize materials and post-processing to off..
PU
More news
Financials (EUR)
Sales 2019 9 150 M
EBIT 2019 1 124 M
Net income 2019 814 M
Debt 2019 1 472 M
Yield 2019 2,10%
P/E ratio 2019 24,4x
P/E ratio 2020 21,5x
EV / Sales2019 2,32x
EV / Sales2020 2,18x
Capitalization 19 766 M
Chart ROYAL DSM
Duration : Period :
Royal DSM Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 114,22  €
Last Close Price 116,00  €
Spread / Highest target 26,7%
Spread / Average Target -1,54%
Spread / Lowest Target -40,5%
EPS Revisions
Managers
NameTitle
Feike Sijbesma Chairman-Management Board & CEO
Robert John Routs Chairman-Supervisory Board
Géraldine Matchett Chief Financial Officer
Pauline F. M. van der Meer Mohr Deputy Chairman
Victoria Franchetti Haynes Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM63.14%21 885
BASF SE17.67%72 577
DUPONT DE NEMOURS, INC.-2.91%52 101
SHIN-ETSU CHEMICAL CO., LTD.45.76%47 340
GROUPE BRUXELLES LAMBERT21.42%15 998
ASAHI KASEI CORPORATION15.09%15 717